Amwell® Announces Results for Third Quarter 2021

Go back to Amwell® Announces Results for Third Quarter 2021

Amwell (AMWL) Tops Q3 EPS by 4c

November 10, 2021 4:10 PM EST

Amwell (NYSE: AMWL) reported Q3 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $62.2 million versus the consensus estimate of $65.35 million.

GUIDANCE:

Amwell sees FY2021 revenue of $246-253 million, versus the consensus of $255... More